|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 276, Issue 20, 17568-17575, May 18, 2001
From the In this study
arachidonate-phospholipid remodeling was investigated in resting and
proliferating human T lymphocytes. Lymphocytes induced to proliferate
with either the mitogen concanavalin A or with anti-CD3 (OKT3) in
combination with interleukin 2 (OKT3/IL-2) showed a greatly accelerated
rate of [3H]arachidonate-phospholipid remodeling
compared with resting lymphocytes or with lymphocytes stimulated with
OKT3 or IL-2 alone. The concanavalin A-stimulated cells showed a 2-fold
increase in the specific activity of CoA-independent transacylase
compared with unstimulated cells, indicating that this enzyme is
inducible. Stimulation with OKT3 resulted in greatly increased
quantities of the group VI calcium-independent phospholipase
A2 but not of the quantity of group IV cytosolic phospholipase A2. However, group IV phospholipase
A2 became phosphorylated in OKT3-stimulated cells, as
determined by decreased electrophoretic mobility. Incubation of cells
with the group VI phospholipase A2 inhibitor, bromoenol
lactone, or the dual group IV/group VI phospholipase A2
inhibitor, methyl arachidonyl fluorophosphonate, did not block
arachidonate-phospholipid remodeling resting or proliferating T cells,
suggesting that these phospholipases A2 were not involved
in arachidonate-phospholipid remodeling. The incubation of
nonproliferating human lymphocytes with inhibitors of CoA-independent
transacylase had little impact on cell survival. In contrast,
OKT3/IL-2-stimulated T lymphocytes were very sensitive to apoptosis
induced by CoA-independent transacylase inhibitors. Altogether these
results indicate that increased arachidonate-phospholipid remodeling is
associated with T cell proliferation and that CoA-independent transacylase may be a novel therapeutic target for proliferative disorders.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||